Modernizing Evidence Synthesis for Evidence-Based Medicine

Clinical Decision Support: The Road to Broad Adoption: Second Edition

Volumn , Issue , 2014, Pages 339-361

  Wallace, Byron C ^a   Dahabreh, Issa J ^a   Schmid, Christopher H ^a   Lau, Joseph ^a   Trikalinos, Thomas A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Evidence based medicine; Medical informatics; Meta analysis; PICO; Systematic review

Indexed keywords

EID: 84902068745     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-398476-0.00012-9     Document Type: Chapter

References (89)

1. Abrams K.R., Jones D.R., Sheldon T.A., Song F. Methods for Meta-analysis in Medical Research 2000, Wiley, Hoboken, NJ.
2. Allen N.C., Bagade S., Mcqueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., et al. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008, 40:827-834.
3. Antman E.M., Lau J., Kupelnick B., Mosteller F., Chalmers T.C. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. JAMA 1992, 268:240-248.
4. Balk E., Chung M., Hadar N., Patel K., Yu W., Trikalinos T., et al. Accuracy of data extraction of non-English language trials with Google Translate. AHRQ Methods Research Reports 2012.
5. Bastian H., Glasziou P., Chalmers I. Seventy-five trials and eleven systematic reviews a day: how will we ever keep up?. PLoS Med. 2010, 7:e1000326.
6. Bekhuis T., Demner-Fushman D. Towards automating the initial screening phase of a systematic review. Stud. Health Technol. Inform 2010, 160:146-150.
7. Bertram L., Mcqueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nat. Genet. 2007, 39:17-23.
8. Borenstein, M., Hedges, L., Higgins, J. & Rothstein, H. 2005. Comprehensive meta-analysis version 2. Biostat. Englewood, NJ.
9. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for reporting of diagnostic accuracy. Clin. Chem. 2003, 49:1-6.
10. Boudin F., Nie J.Y., Dawes M. Clinical information retrieval using document and PICO structure. Assoc. Comput. Linguistics 2010, 822-830.
11. Boudin F., Nie J.Y., Dawes M. Positional language models for clinical information retrieval. Assoc. Comput. Linguistics 2010, 108-115.
12. Breslow R.A., Ross S.A., Weed D.L. Quality of reviews in epidemiology. Am. J. Public Health 1998, 88:475-477.
13. Castaldi P.J., Cho M.H., Cohn M., Langerman F., Moran S., Tarragona N., et al. The COPD genetic association compendium: a comprehensive online database of COPD genetic associations. Hum. Mol. Genet. 2010, 19:526-534.
14. Clarke M.J., Stewart L.A. Obtaining data from randomised controlled trials: how much do we need for reliable and informative meta-analyses?. BMJ 1994, 309:1007-1010.
15. Cohen A.M., Hersh W.R., Peterson K., Yen P.Y. Reducing workload in systematic review preparation using automated citation classification. J. Am. Med. Inform. Assoc. 2006, 13:206-219.
16. Collins R., Gray R., Godwin J., Peto R. Avoidance of large biases and large random errors in the assessment of moderate treatment effects: the need for systematic overviews. Stat. Med. 1987, 6:245-254.
17. Cook D.J., Mulrow C.D., Haynes R.B. Systematic reviews: synthesis of best evidence for clinical decisions. Ann. Intern. Med. 1997, 126:376-380.
18. Cooper H., Hedges L.V., Valentine J.C. Handbook of Research Synthesis and Meta-Analysis 2009, Russell Sage Foundation, New York, NY.
19. Dahabreh I.J., Chung M., Kitsios G.D., Terasawa T., Raman G., Tatsioni A., et al. Survey of the methods and reporting practices in published meta-analyses of test performance: 1987 to 2009. Research Synthesis Methods 2013, 4(3):242-255.
20. Demner-Fushman D., Lin J. Answering clinical questions with knowledge-based and statistical techniques. Comput. Linguistics 2007, 33:63-103.
21. Dickersin K. Systematic reviews in epidemiology: why are we so far behind?. Int. J. Epidemiol. 2002, 31:6-12.
22. Egger M., Schneider M., Davey Smith G. Spurious precision? Meta-analysis of observational studies. BMJ 1998, 316:140-144.
23. Egger M., Smith G.D., Altman D. Systematic Reviews in Health Care: Meta-analysis in Context 2008, Wiley, Hoboken, NJ.
24. Greenland S. Invited commentary: a critical look at some popular meta-analytic methods. Am. J. Epidemiol. 1994, 140:290-296.
25. Greenland S., O'rourke K. On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics 2001, 2:463-471.
26. Hedges L.V., Olkin I., Statistiker M., Olkin I., Olkin I. Statistical Methods for Meta-analysis 1985, Academic Press, New York.
27. Higgins J.P., Whitehead A. Borrowing strength from external trials in a meta-analysis. Stat. Med. 1996, 15:2733-2749.
28. Cochrane handbook for systematic reviews of interventions 2008, vol. 5. Wiley-Blackwell, Chichester, Available from: http://www.cochrane.org/.
29. IOM Finding what works in healthcare. Standards for systematic reviews. Institute of Medicine 2011, The National Academies Press.
30. Ip S., Hadar N., Keefe S., Parkin C., Iovin R., Balk E.M., et al. A web-based archive of systematic review data. Syst. Rev. 2012, 1:15.
31. Jackson D., Riley R., White I.R. Multivariate meta-analysis: potential and promise. Stat. Med. 2011, 30:2481-2498.
32. Jadad A.R., Cook D.J., Jones A., Klassen T.P., Tugwell P., Moher M., et al. Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 1998, 280:278-280.
33. Juni P., Holenstein F., Sterne J., Bartlett C., Egger M. Direction and impact of language bias in meta-analyses of controlled trials: empirical study. Int. J. Epidemiol. 2002, 31:115-123.
34. Kim S.N., Martinez D., Cavedon L. Automatic classification of sentences for evidence based medicine. BMC Bioinformatics 2010, 13-22.
35. Kim S.N., Martinez D., Cavedon L., Yencken L. Automatic classification of sentences to support evidence based medicine. BMC Bioinformatics 2011, 12(Suppl 2):S5.
36. Kiritchenko S., De Bruijn B., Carini S., Martin J., Sim I. ExaCT: automatic extraction of clinical trial characteristics from journal publications. BMC Med. Inform Decis. Mak. 2010, 10:56.
37. Kovalchik S.A. Survey finds that most meta-analysts do not attempt to collect individual patient data. J. Clin. Epidemiol. 2012, 65:1296-1299.
38. Krupski T.L., Dahm P., Fesperman S.F., Schardt C.M. How to perform a literature search. J. Urol. 2008, 179:1264-1270.
39. Laird N.M., Mosteller F. Some statistical methods for combining experimental results. Int. J. Technol. Assess. Health Care 1990, 6:5-30.
40. Lau J., Antman E.M., Jimenez-Silva J., Kupelnick B., Mosteller F., Chalmers T.C. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N. Engl. J. Med. 1992, 327:248-254.
41. Lau J., Ioannidis J.P., Schmid C.H. Summing up evidence: one answer is not always enough. Lancet 1998, 351:123-127.
42. Lewis S., Clarke M. Forest plots: trying to see the wood and the trees. BMJ 2001, 322:1479-1480.
43. Lill C.M., Roehr J.T., Mcqueen M.B., Kavvoura F.K., Bagade S., Schjeide B.M., et al. Comprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database. PLoS Genet. 2012, 8:e1002548.
44. Lu G., Ades A.E. Combination of direct and indirect evidence in mixed treatment comparisons. Stat. Med. 2004, 23:3105-3124.
45. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat. Med. 2002, 21:2313-2324.
46. Lunn D., Spiegelhalter D., Thomas A., Best N. The BUGS project: Evolution, critique and future directions. Stat. Med. 2009, 28:3049-3067.
47. Manning C.D.A.R., Shutze H. Introduction to Information Retrieval 2008, Cambridge University Press.
48. Matchar D.B. Introduction to the Methods Guide for Medical Test Reviews. J. Gen. Intern. Med. 2012, 27(Suppl 1):S4-10.
49. Mavridis D., Salanti G. A practical introduction to multivariate meta-analysis. Stat. Methods Med. Res. 2013, 22:133-158.
50. Moher D., Cook D.J., Eastwood S., Olkin I., Rennie D., Stroup D.F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999, 354:1896-1900.
51. Moher D., Jadad A.R., Nichol G., Penman M., Tugwell P., Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Control Clin. Trials 1995, 16:62-73.
52. Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann. Intern. Med. 2009, 151:264-269. W64.
53. Mulrow C.D. The medical review article: state of the science. Ann. Intern. Med. 1987, 106:485-488.
54. Neumann, P., Cohen, J., et al., 2013. The Cost-Effectiveness Analysis Registry [Online]. Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center. Available: . http://www.cearegistry.org.
55. Petitti D.B. Meta-analysis, Decision Analysis, and Cost-effectiveness Analysis: Methods for Quantitative Synthesis in Medicine 1999, Oxford University Press, Cary, NC.
56. Peto R., Collins R., Gray R. Large-scale randomized evidence: large, simple trials and overviews of trials. Ann. N. Y. Acad. Sci. 1993, 703:314-340.
57. Petticrew M. Systematic reviews from astronomy to zoology: myths and misconceptions. BMJ 2001, 322:98-101.
58. Plummer, M. (2003, March). JAGS: a program for analysis of bayesian graphical models using gibbs sampling. In Proceedings of the 3rd International Workshop on Distributed Statistical Computing (DSC 2003), pp. 20-22.
59. Reitsma J.B., Glas A.S., Rutjes A.W., Scholten R.J., Bossuyt P.M., Zwinderman A.H. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J. Clin. Epidemiol. 2005, 58:982-990.
60. Riley R.D., Simmonds M.C., Look M.P. Evidence synthesis combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. J. Clin. Epidemiol. 2007, 60:431-439.
61. Rothman K.J., Greenland S., Lash T.L. Modern Epidemiology 2008, Lippincott Williams & Wilkins, Philadelphia. third ed.
62. Rucker G. Network meta-analysis, electrical networks and graph theory. Res. Synth. Methods 2012, 3:312-324.
63. Rutter C.M., Gatsonis C.A. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat. Med. 2001, 20:2865-2884.
64. Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res. Synth. Methods 2012, 3:80-97.
65. Sampson M., Barrowman N.J., Moher D., Klassen T.P., Pham B., Platt R., et al. Should meta-analysts search Embase in addition to Medline?. J. Clin. Epidemiol. 2003, 56:943-955.
66. Savovic J., Jones H.E., Altman D.G., Harris R.J., Juni P., Pildal J., et al. Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Ann. Intern. Med. 2012, 157:429-438.
67. Schmid C. Exploring heterogeneity in randomized trials via meta-analysis. Drug Information J. 1999, 33:211-224.
68. Schmid C.H., Stark P.C., Berlin J.A., Landais P., Lau J. Meta-regression detected associations between heterogeneous treatment effects and study-level, but not patient-level, factors. J. Clin. Epidemiol. 2004, 57:683-697.
69. Shrier I., Boivin J.F., Steele R.J., Platt R.W., Furlan A., Kakuma R., et al. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles. Am. J. Epidemiol. 2007, 166:1203-1209.
70. Sidik K., Jonkman J.N. A comparison of heterogeneity variance estimators in combining results of studies. Stat. Med. 2007, 26:1964-1981.
71. Stefanison, I.E., Henry. 2001. DistillerSR [Online]. Available: . http://systematic-review.net.
72. Sterne J.A., Juni P., Schulz K.F., Altman D.G., Bartlett C., Egger M. Statistical methods for assessing the influence of study characteristics on treatment effects in 'meta-epidemiological' research. Stat. Med. 2002, 21:1513-1524.
73. Sterne J.A., Sutton A.J., Ioannidis J.P., Terrin N., Jones D.R., Lau J., et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011, 343:d4002.
74. Stewart L.A., Tierney J.F. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval. Health Prof. 2002, 25:76-97.
75. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
76. Terasawa T., Trikalinos N.A., Djulbegovic B., Trikalinos T.A. Comparative efficacy of first-line therapies for advanced-stage chronic lymphocytic leukemia: a multiple-treatment meta-analysis. Cancer Treat. Rev. 2013, 39:340-349.
77. Thompson S.G., Higgins J.P. How should meta-regression analyses be undertaken and interpreted?. Stat. Med. 2002, 21:1559-1573.
78. van Valkenhoef, G., Lu, G., de Brock, B., Hillege, H., Ades, A.E., Welton, N.J., 2012. Automating network meta-analysis. Res. Synth. Methods, 3, 285-299.
79. Van Houwelingen H.C., Arends L.R., Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat. Med. 2002, 21:589-624.
80. Van Walraven C. Individual patient meta-analysis - rewards and challenges. J. Clin. Epidemiol. 2010, 63:235-237.
81. Verbeke M., Van Asch V., Morante R., Frasconi P., Daelemans W., De Raedt L. A statistical relational learning approach to identifying evidence based medicine categories. Empirical Methods Nat. Lang. Process. (EMNLP) 2012.
82. Vickers A., Goyal N., Harland R., Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Control Clin. Trials 1998, 19:159-166.
83. Wallace B., Dahabreh I., Trikalinos T., Lau J., Trow P., Schmid C. Closing the gap between methodologists and end-users: r as a computational back-end. J. Stat. Softw. 2012, 49:1-15.
84. Wallace B.C., Schmid C.H., Lau J., Trikalinos T.A. Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med. Res. Methodol. 2009, 9:80.
85. Wallace B.C., Small K., Brodley C.E., Lau J., Schmid C.H., Bertram L., et al. Toward modernizing the systematic review pipeline in genetics: efficient updating via data mining. Genet. Med. 2012, 14(7):663-669.
86. Wallace B.C., Small K., Brodley C.E., Trikalinos T.A. Active learning for biomedical citation screening. Proc. ACM SIGKDD Conf. Knowl. Discovery Data Min. (KDD) 2010, 173-182.
87. Wallace B.C., Trikalinos T.A., Lau J., Brodley C., Schmid C.H. Semi-automated screening of biomedical citations for systematic reviews. BMC Bioinf. 2010, 11:55.
88. Welton, N.J., Sutton, A.J., Cooper, N.J., Abrams, K.R., Ades, A.E., 2012. Evidence Synthesis for Decision Making in Healthcare, vol. 132. Wiley.
89. Wilson D.B., Lipsey M.W. Practical Meta-Analysis 2000, Sage Publications, Thousand Oaks, California.